Vaccination in the peripheral stem cell transplant setting for multiple myeloma: the use of autologous tumor cells with an allogeneic GM-CSF producing cell line
Phase of Trial: Phase I/II
Latest Information Update: 31 Oct 2005
At a glance
- Drugs Granulocyte macrophage colony stimulating factor; Tumour cell vaccine-GVAX
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 Oct 2005 New trial record.